These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17964172)

  • 1. Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14alpha-demethylase (CYP51).
    Korosec T; Acimovic J; Seliskar M; Kocjan D; Tacer KF; Rozman D; Urleb U
    Bioorg Med Chem; 2008 Jan; 16(1):209-21. PubMed ID: 17964172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase.
    Harwood HJ; Petras SF; Hoover DJ; Mankowski DC; Soliman VF; Sugarman ED; Hulin B; Kwon Y; Gibbs EM; Mayne JT; Treadway JL
    J Lipid Res; 2005 Mar; 46(3):547-63. PubMed ID: 15604516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of mammalian lanosterol 14 alpha-demethylase: a possible strategy for cholesterol lowering.
    Walker KA; Kertesz DJ; Rotstein DM; Swinney DC; Berry PW; So OY; Webb AS; Watson DM; Mak AY; Burton PM
    J Med Chem; 1993 Jul; 36(15):2235-7. PubMed ID: 8340925
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors.
    Hajjaj H; Macé C; Roberts M; Niederberger P; Fay LB
    Appl Environ Microbiol; 2005 Jul; 71(7):3653-8. PubMed ID: 16000773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridylethanol(phenylethyl)amines are non-azole, highly selective Candida albicans sterol 14α-demethylase inhibitors.
    Ogris I; Zelenko U; Sosič I; Gobec M; Skubic C; Ivanov M; Soković M; Kocjan D; Rozman D; Golič Grdadolnik S
    Bioorg Chem; 2021 Jan; 106():104472. PubMed ID: 33261849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of lanosterol-14 alpha-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles.
    Trösken ER; Adamska M; Arand M; Zarn JA; Patten C; Völkel W; Lutz WK
    Toxicology; 2006 Nov; 228(1):24-32. PubMed ID: 16989930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
    Ekins S; Mankowski DC; Hoover DJ; Lawton MP; Treadway JL; Harwood HJ
    Drug Metab Dispos; 2007 Mar; 35(3):493-500. PubMed ID: 17194716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterogenic lanosterol 14alpha-demethylase (CYP51) is an immediate early response gene.
    Fink M; Acimovic J; Rezen T; Tansek N; Rozman D
    Endocrinology; 2005 Dec; 146(12):5321-31. PubMed ID: 16123160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of lanosterol and its major metabolite FF-MAS in an inhibition assay of CYP51 by azoles with atmospheric pressure photoionization based LC-MS/MS.
    Trösken ER; Straube E; Lutz WK; Völkel W; Patten C
    J Am Soc Mass Spectrom; 2004 Aug; 15(8):1216-21. PubMed ID: 15276168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lanosterol 14 alpha-demethylase (P45014DM): effects of P45014DM inhibitors on sterol biosynthesis downstream of lanosterol.
    Tuck SF; Patel H; Safi E; Robinson CH
    J Lipid Res; 1991 Jun; 32(6):893-902. PubMed ID: 1940622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lanosterol analogs: dual-action inhibitors of cholesterol biosynthesis.
    Frye LL; Leonard DA
    Crit Rev Biochem Mol Biol; 1999; 34(2):123-40. PubMed ID: 10333389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of mammalian lanosterol 14 alpha-demethylase by RS-21607 in vitro and in vivo.
    Swinney DC; So OY; Watson DM; Berry PW; Webb AS; Kertesz DJ; Shelton EJ; Burton PM; Walker KA
    Biochemistry; 1994 Apr; 33(15):4702-13. PubMed ID: 8161528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cAMP-responsive element binding site is essential for sterol regulation of the human lanosterol 14alpha-demethylase gene (CYP51).
    Halder SK; Fink M; Waterman MR; Rozman D
    Mol Endocrinol; 2002 Aug; 16(8):1853-63. PubMed ID: 12145339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate-based inhibitors of lanosterol 14 alpha-methyl demethylase: I. Assessment of inhibitor structure-activity relationship and cholesterol biosynthesis inhibition properties.
    Trzaskos JM; Ko SS; Magolda RL; Favata MF; Fischer RT; Stam SH; Johnson PR; Gaylor JL
    Biochemistry; 1995 Aug; 34(30):9670-6. PubMed ID: 7626636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular design of two sterol 14alpha-demethylase homology models and their interactions with the azole antifungals ketoconazole and bifonazole.
    Rupp B; Raub S; Marian C; Höltje HD
    J Comput Aided Mol Des; 2005 Mar; 19(3):149-63. PubMed ID: 16059669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of CYP51 from Mycobacterium avium.
    Pietila MP; Vohra PK; Sanyal B; Wengenack NL; Raghavakaimal S; Thomas CF
    Am J Respir Cell Mol Biol; 2006 Aug; 35(2):236-42. PubMed ID: 16543605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classical QSAR study on chromene derivatives as lanosterol 14alpha- demethylase inhibitor: a non azole antifungal target.
    Vasanthanathan P; Lakshmi M; Babu MA; Kaskhedikar SG
    Med Chem; 2006 Jul; 2(4):363-7. PubMed ID: 16848747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic adenosine 3',5'-monophosphate(cAMP)/cAMP-responsive element modulator (CREM)-dependent regulation of cholesterogenic lanosterol 14alpha-demethylase (CYP51) in spermatids.
    Rozman D; Fink M; Fimia GM; Sassone-Corsi P; Waterman MR
    Mol Endocrinol; 1999 Nov; 13(11):1951-62. PubMed ID: 10551787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lanosterol 14alpha-demethylase (CYP51)--a cholesterol biosynthetic enzyme involved in production of meiosis activating sterols in oocytes and testis--a minireview.
    Rozman D
    Pflugers Arch; 2000; 439(3 Suppl):R56-7. PubMed ID: 10653142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 15alpha-fluoro-24,25-dihydrolanosterol as a potential inhibitor and/or mechanistic probe for lanosterol 14alpha-demethylase.
    Morisaki M; Igata T; Yamamoto S
    Chem Pharm Bull (Tokyo); 2000 Oct; 48(10):1474-9. PubMed ID: 11045454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.